24374-1-AP

antibody from Proteintech Group

Targeting: CR2 C3DR, CD21

ELISA (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Antibody Data

Product number

24374-1-AP

Provider

Proteintech Group

Product name

CD21 antibody

Antibody type

Polyclonal

Description

CD21 antibody (Cat. #24374-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IHC,ELISA.

Reactivity

Human

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

20ul, 150ul

References

Submitted references

MIF-expressing tumor cells mediate immunotherapeutic resistance in esophageal squamous cell carcinoma.

Song J, Song X, Xie Y, Guo H, Cun Y
Theranostics 2026;16(3):1613-1629

---

Characteristics of tertiary lymphoid structures in prostate cancer and the impact of neoadjuvant therapy on their formation and maturation.

Liu S, Yu Y, Zhou J, Yang L, Yan X, Liu X, Ma K, Liu L, Wang X, Zhao C, Dong Q
Frontiers in immunology 2025;16:1663396

---

Intratumoral bacterial load and tertiary lymphoid structure density in hepatocellular carcinoma: association and prognostic significance.

Qu S, Jia W, Liu X, Yao Q, Chen C, Zhao Z, Nie Y, Chang F, Yang Z, Peng C, Wang Y, Song W
Frontiers in immunology 2025;16:1652433

---

The influence of microsatellite status on tertiary lymphoid structures and lymph node metastasis in colorectal cancer.

Wang K, Zhou S, Wang H, Zhang X, Cheng W, Sun Y, Ding C, Guan W
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2025 Nov;27(11):4214-4220

---

Single-cell landscape identified SERPINB9 as a key player contributing to stemness and metastasis in non-seminomas.

Bian Z, Chen B, Shi G, Yuan H, Zhou Y, Jiang B, Li L, Su H, Zhang Y
Cell death & disease 2024 Nov 11;15(11):812

---

Single-cell transcriptome sequencing of B-cell heterogeneity and tertiary lymphoid structure predicts breast cancer prognosis and neoadjuvant therapy efficacy.

Wang Q, Sun K, Liu R, Song Y, Lv Y, Bi P, Yang F, Li S, Zhao J, Li X, Chen D, Mei J, Yang R, Chen K, Liu D, Tang S
Clinical and translational medicine 2023 Aug;13(8):e1346

---

A Standardized Analysis of Tertiary Lymphoid Structures in Human Melanoma: Disease Progression- and Tumor Site-Associated Changes With Germinal Center Alteration.

Werner F, Wagner C, Simon M, Glatz K, Mertz KD, Läubli H, Griss J, Wagner SN
Frontiers in immunology 2021;12:675146

---

B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma.

Griss J, Bauer W, Wagner C, Simon M, Chen M, Grabmeier-Pfistershammer K, Maurer-Granofszky M, Roka F, Penz T, Bock C, Zhang G, Herlyn M, Glatz K, Läubli H, Mertz KD, Petzelbauer P, Wiesner T, Hartl M, Pickl WF, Somasundaram R, Steinberger P, Wagner SN
Nature communications 2019 Sep 13;10(1):4186